{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:46:14Z","timestamp":1774262774952,"version":"3.50.1"},"reference-count":50,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T00:00:00Z","timestamp":1425427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"National Basic Research Plan (973 Plan) Foundation of China","award":["2010CB735602"],"award-info":[{"award-number":["2010CB735602"]}]},{"name":"National Key Technology R&D Program of Eleventh Five-Year Plan","award":["2007BAI41B03"],"award-info":[{"award-number":["2007BAI41B03"]}]},{"name":"National Science and Technology Major Project for \u201cMajor New Drugs Innovation and Development\u201d","award":["2012XZ09505"],"award-info":[{"award-number":["2012XZ09505"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes"],"published-print":{"date-parts":[[2015,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The safe use of medications in pregnant females, their embryos and in offspring is important. The aim of the present study was to evaluate embryotoxicity of metformin (<jats:styled-content style=\"fixed-case\">MET<\/jats:styled-content>) compared with other hypoglycemic drugs (rosiglitazone [<jats:styled-content style=\"fixed-case\">RSG<\/jats:styled-content>] and glimepiride [<jats:styled-content style=\"fixed-case\">GLIM<\/jats:styled-content>]), the anticancer drug 5\u2010fluorouracil (5\u2010<jats:styled-content style=\"fixed-case\">FU<\/jats:styled-content>), the anti\u2010epileptic drug diphenylhydantoin (<jats:styled-content style=\"fixed-case\">DPH<\/jats:styled-content>), the antibiotic penicillin G (<jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>en<jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>), and the cyclo\u2010oxygenase (<jats:styled-content style=\"fixed-case\">COX<\/jats:styled-content>)\u20102 inhibitor nimesulide (<jats:styled-content style=\"fixed-case\">NIM<\/jats:styled-content>) in an embryonic stem cell test (<jats:styled-content style=\"fixed-case\">EST<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Differences in the expression of developmental marker genes following treatment with the test compounds during the course of differentiation (from embryonic stem cell<jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>3 (<jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>3 cells) to myocardial cells) were determined using real\u2010time quantitative polymerase chain reaction. In these studies, 5\u2010<jats:styled-content style=\"fixed-case\">FU<\/jats:styled-content>was used as a positive control and<jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>en<jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>was used as a negative control. The cytotoxicity of these drugs against<jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>3 cells and 3<jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>3 fibroblasts was determined by the 3\u2010(4,5\u2010dimethyl\u20102 thiazoyl)\u20102,5\u2010diphenyl\u20102<jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>\u2010tetrazolium bromide (<jats:styled-content style=\"fixed-case\">MTT<\/jats:styled-content>) assay. Embryotoxicity was classified according to the prediction model of<jats:styled-content style=\"fixed-case\">EST<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At concentrations &gt;800\u2009<jats:italic>\u03bc<\/jats:italic>g\/mL<jats:styled-content style=\"fixed-case\">MET<\/jats:styled-content>had a greater cytotoxic effect on<jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>3 cells than 3<jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>3 fibroblasts. At the highest concentration of<jats:styled-content style=\"fixed-case\">MET<\/jats:styled-content>(5\u2009mg\/mL), the cell viability of<jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>3 cells and 3<jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>3 fibroblasts was &lt;10% and &gt;30%, respectively. The size of the embryonic body (<jats:styled-content style=\"fixed-case\">EB<\/jats:styled-content>) differentiation area was almost the same over the concentration range 50\u2013200\u2009<jats:italic>\u03bc<\/jats:italic>g\/mL<jats:styled-content style=\"fixed-case\">MET<\/jats:styled-content>, and there was no significant difference in<jats:styled-content style=\"fixed-case\">EB<\/jats:styled-content>differentiation area until a concentration of 400\u2009<jats:italic>\u03bc<\/jats:italic>g\/mL<jats:styled-content style=\"fixed-case\">MET<\/jats:styled-content>. At a concentration of 800\u2009<jats:italic>\u03bc<\/jats:italic>g\/mL<jats:styled-content style=\"fixed-case\">MET<\/jats:styled-content>, the size of<jats:styled-content style=\"fixed-case\">EB<\/jats:styled-content>outgrowth was significantly reduced. The same assays revealed<jats:styled-content style=\"fixed-case\">GLIM<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\">RSG<\/jats:styled-content>, and<jats:styled-content style=\"fixed-case\">NIM<\/jats:styled-content>to be weakly embryotoxic substances.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Based on the<jats:styled-content style=\"fixed-case\">EST<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\">MET<\/jats:styled-content>can be classified as a weakly embryotoxic substance, which suggests that it should be prescribed with caution to pregnant women with gestational diabetes.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1753-0407.12251","type":"journal-article","created":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T13:18:29Z","timestamp":1418217509000},"page":"839-849","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A toxicology study to evaluate the embryotoxicity of metformin compared with the hypoglycemic drugs, the anticancer drug, the anti\u2010epileptic drug, the antibiotic, and the cyclo\u2010oxygenase (COX)\u20102 inhibitor"],"prefix":"10.1111","volume":"7","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[{"name":"Shenyang Pharmaceutical University Shenyang China"},{"name":"Tianjin Center for Drug Safety Assessment and Research Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tianjin Center for Drug Safety Assessment and Research Tianjin China"},{"name":"Tianjin University of Traditional Chinese Medicine Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Tianjin Center for Drug Safety Assessment and Research Tianjin China"},{"name":"Tianjin University of Traditional Chinese Medicine Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhai","family":"Chai","sequence":"additional","affiliation":[{"name":"Tianjin Center for Drug Safety Assessment and Research Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuping","family":"Shen","sequence":"additional","affiliation":[{"name":"Tianjin Center for Drug Safety Assessment and Research Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongpeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tianjin Center for Drug Safety Assessment and Research Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changxiao","family":"Liu","sequence":"additional","affiliation":[{"name":"Shenyang Pharmaceutical University Shenyang China"},{"name":"State Key Laboratory of Drug Delivery Technology and Pharmacokinetics Tianjin Institute of Pharmaceutical Research Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,3,4]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"1690","article-title":"Genetic effects of januvia and galvus alone or with metformin on pregnant female mice and their embryos","volume":"12","author":"Roshdy HM","year":"2013","journal-title":"World Appl Sci J"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03361.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2010.02763.x"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2587"},{"key":"e_1_2_8_6_1","article-title":"A follow\u2010up of a randomised study of metformin and insulin in gestational diabetes mellitus: Growth and development of the children at the age of 18 months","author":"Ijas H","year":"2014","journal-title":"Br J Obstet Gynaecol"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000080"},{"key":"e_1_2_8_8_1","first-page":"179","article-title":"The safety of oral hypoglycemic agents in the first trimester of pregnancy: A meta\u2010analysis","volume":"10","author":"Gutzin SJ","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2007.01.013"},{"key":"e_1_2_8_10_1","volume-title":"The Principles of Humane Experimental Technique","author":"Russell WMS","year":"1959"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/026119290403200307"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2006.01.017"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2007.07.013"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.98106571"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(84)90020-6"},{"key":"e_1_2_8_16_1","first-page":"46","volume-title":"Concepts in Toxicology","author":"Schmid BP","year":"1985"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-2333(01)00074-1"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612043383700"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfh100"},{"key":"e_1_2_8_20_1","first-page":"119","article-title":"The embryonic stem cell test, an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells","volume":"10","author":"Spielmann H","year":"1997","journal-title":"Toxicol In Vitro"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-2333(99)00046-6"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/026119290403200305"},{"key":"e_1_2_8_23_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/oso\/9780198550006.003.0002","volume-title":"Embryonic Stem Cells. A Practical Approach","author":"Brook FA","year":"2006"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2007.06.014"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2003.10.015"},{"key":"e_1_2_8_26_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/026119290102900322","article-title":"Preliminary results of the ECVAM validation study on three in vitro embryotoxicity tests","volume":"29","author":"Spielmann H","year":"2001","journal-title":"Altern Lab Anim"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7254.2005.00076.x"},{"key":"e_1_2_8_28_1","doi-asserted-by":"crossref","first-page":"11905","DOI":"10.1016\/S0021-9258(19)38485-6","article-title":"Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro","volume":"265","author":"Robbins J","year":"1990","journal-title":"J Biol Chem"},{"key":"e_1_2_8_29_1","doi-asserted-by":"crossref","first-page":"22419","DOI":"10.1016\/S0021-9258(18)54589-0","article-title":"Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study","volume":"266","author":"Sanchez A","year":"1991","journal-title":"J Biol Chem"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-2333(01)00007-8"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/026119290203000204"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/026119290203000205"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318190a459"},{"key":"e_1_2_8_35_1","doi-asserted-by":"crossref","first-page":"672","DOI":"10.47102\/annals-acadmedsg.V36N8p672","article-title":"Oral hypoglycaemic agents for diabetes in pregnancy An appraisal of the current evidence for oral anti\u2010diabetic drug use in pregnancy","volume":"36","author":"Ho FL","year":"2007","journal-title":"Ann Acad Med Singapore"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(03)00248-7"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-1048fje"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2003.09.019"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072761"},{"key":"e_1_2_8_40_1","first-page":"1","article-title":"The effects of agnucaston and metformin on the chromosomes of pregnant females and their embryos","volume":"8","author":"Roshdy HM","year":"2010","journal-title":"Nat Sci"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(01)02825-4"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.10.1189"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm529"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-011-0249-0"},{"key":"e_1_2_8_45_1","first-page":"332","article-title":"COX\u20102 selective inhibitors cardiac toxicity: Getting to the heart of the matter","volume":"7","author":"Davies NM","year":"2004","journal-title":"J Pharm Pharm Sci"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0890-6238(03)00045-5"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2005.08.009"},{"key":"e_1_2_8_48_1","first-page":"1476","article-title":"Reversible infertility from nonsteroidal anti\u2010inflammatory drugs","volume":"125","author":"Skomsvoll JF","year":"2005","journal-title":"Tidsskr Nor Laegeforen"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225080-00001"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.3109\/01480540903390018"},{"key":"e_1_2_8_51_1","first-page":"439","article-title":"Genotoxicity of nimesulide in murine bone marrow cells","volume":"17","author":"Khan PK","year":"2003","journal-title":"In Vivo"}],"container-title":["Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1753-0407.12251","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1753-0407.12251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T19:40:20Z","timestamp":1717616420000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1753-0407.12251"}},"subtitle":["\u8bc4\u4ef7\u4e8c\u7532\u53cc\u80cd\u4e0e\u964d\u7cd6\u836f\u3001\u6297\u764c\u836f\u3001\u6297\u766b\u75eb\u836f\u3001\u6297\u83cc\u836f\u4ee5\u53ca\u73af\u6c27\u5408\u9176\u20102\u6291\u5236\u5242\u76f8\u6bd4\u7684\u80da\u80ce\u6bd2\u6027\u7684\u6bd2\u7406\u5b66\u7814\u7a76"],"short-title":[],"issued":{"date-parts":[[2015,3,4]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1111\/1753-0407.12251"],"URL":"https:\/\/doi.org\/10.1111\/1753-0407.12251","archive":["Portico"],"relation":{},"ISSN":["1753-0393","1753-0407"],"issn-type":[{"value":"1753-0393","type":"print"},{"value":"1753-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,4]]},"assertion":[{"value":"2014-09-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-11-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-03-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}